• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症与糖尿病:衰老带来的有害关联。

Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age.

机构信息

Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, Interdisciplinary Department of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.

Unit of Endocrinology, Diabetology, Dietetics and Clinical Nutrition, Sant Anna Hospital, 22020 San Fermo della Battaglia, Italy.

出版信息

Nutrients. 2023 Dec 25;16(1):63. doi: 10.3390/nu16010063.

DOI:10.3390/nu16010063
PMID:38201893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10780932/
Abstract

Sarcopenia is an age-related clinical complaint characterized by the progressive deterioration of skeletal muscle mass and strength over time. Type 2 diabetes (T2D) is associated with faster and more relevant skeletal muscle impairment. Both conditions influence each other, leading to negative consequences on glycemic control, cardiovascular risk, general health status, risk of falls, frailty, overall quality of life, and mortality. PubMed/Medline, Scopus, Web of Science, and Google Scholar were searched for research articles, scientific reports, observational studies, clinical trials, narrative and systematic reviews, and meta-analyses to review the evidence on the pathophysiology of di-abetes-induced sarcopenia, its relevance in terms of glucose control and diabetes-related outcomes, and diagnostic and therapeutic challenges. The review comprehensively addresses key elements for the clinical definition and diagnostic criteria of sarcopenia, the pathophysiological correlation be-tween T2D, sarcopenia, and related outcomes, a critical review of the role of antihyperglycemic treatment on skeletal muscle health, and perspectives on the role of specific treatment targeting myokine signaling pathways involved in glucose control and the regulation of skeletal muscle metabolism and trophism. Prompt diagnosis and adequate management, including lifestyle inter-vention, health diet programs, micronutrient supplementation, physical exercise, and pharmaco-logical treatment, are needed to prevent or delay skeletal muscle deterioration in T2D.

摘要

肌肉减少症是一种与年龄相关的临床病症,其特征是随着时间的推移,骨骼肌质量和力量逐渐恶化。2 型糖尿病(T2D)与更快和更相关的骨骼肌损伤有关。这两种情况相互影响,导致血糖控制、心血管风险、总体健康状况、跌倒风险、虚弱、整体生活质量和死亡率的负面后果。我们在 PubMed/Medline、Scopus、Web of Science 和 Google Scholar 上搜索了研究文章、科学报告、观察性研究、临床试验、叙述性和系统性综述以及荟萃分析,以综述糖尿病引起的肌肉减少症的病理生理学、其在血糖控制和糖尿病相关结局方面的相关性以及诊断和治疗方面的挑战的证据。本综述全面介绍了肌肉减少症的临床定义和诊断标准的关键要素、T2D、肌肉减少症和相关结局之间的病理生理学相关性、抗高血糖治疗对骨骼肌健康的作用的批判性回顾,以及针对涉及葡萄糖控制和骨骼肌代谢和营养调节的肌因子信号通路的特定治疗在血糖控制中的作用的观点。需要及时诊断和适当管理,包括生活方式干预、健康饮食计划、微量营养素补充、体育锻炼和药物治疗,以预防或延缓 T2D 中的骨骼肌恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe0/10780932/6b7ce09f4832/nutrients-16-00063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe0/10780932/6b7ce09f4832/nutrients-16-00063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe0/10780932/6b7ce09f4832/nutrients-16-00063-g001.jpg

相似文献

1
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age.肌肉减少症与糖尿病:衰老带来的有害关联。
Nutrients. 2023 Dec 25;16(1):63. doi: 10.3390/nu16010063.
2
Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia's ageing population?肌肉减少症:澳大利亚老龄化人口 2 型糖尿病的潜在病因和后果?
Med J Aust. 2016 Oct 3;205(7):329-33. doi: 10.5694/mja16.00446.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Mitochondrial transplantation as a possible therapeutic option for sarcopenia.线粒体移植作为治疗肌肉减少症的一种可能的治疗选择。
J Mol Med (Berl). 2023 Jun;101(6):645-669. doi: 10.1007/s00109-023-02326-3. Epub 2023 May 20.
5
Sarcopenia, frailty and type 2 diabetes mellitus (Review).肌肉减少症、衰弱与 2 型糖尿病(综述)。
Mol Med Rep. 2021 Dec;24(6). doi: 10.3892/mmr.2021.12494. Epub 2021 Oct 15.
6
Changes and Risk Factors of Skeletal Muscle Mass and Strength in Patients with Type 2 Diabetes over 60 Years Old: A Cross-Sectional Study from China.中国 60 岁以上 2 型糖尿病患者骨骼肌量和力量的变化及影响因素:一项横断面研究。
J Diabetes Res. 2020 Sep 25;2020:9815485. doi: 10.1155/2020/9815485. eCollection 2020.
7
Sarcopenia as a Little-Recognized Comorbidity of Type II Diabetes Mellitus: A Review of the Diagnosis and Treatment.肌肉减少症作为 II 型糖尿病的一种未被充分认识的合并症:诊断与治疗的综述。
Nutrients. 2023 Sep 26;15(19):4149. doi: 10.3390/nu15194149.
8
Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses.营养干预措施对改善老年人肌肉量、肌肉力量和身体机能的效果:系统评价和荟萃分析的伞状综述。
Nutr Rev. 2021 Jan 9;79(2):121-147. doi: 10.1093/nutrit/nuaa011.
9
The effect of Tai Chi in elderly individuals with sarcopenia and frailty: A systematic review and meta-analysis of randomized controlled trials.太极拳对伴有肌少症和衰弱的老年人的影响:系统评价和随机对照试验的荟萃分析。
Ageing Res Rev. 2022 Dec;82:101747. doi: 10.1016/j.arr.2022.101747. Epub 2022 Oct 9.
10
Sarcopenia and chronic illness: from diagnosis to treatment approaches.肌少症与慢性病:从诊断到治疗方法。
Recenti Prog Med. 2021 Nov;112(11):720-727. doi: 10.1701/3696.36850.

引用本文的文献

1
Functional benefits of ultra-high hydrostatic pressurized brown rice on cognition, apathy, and bone health in older adults: A 12-month randomized controlled trial.超高静压处理糙米对老年人认知、冷漠及骨骼健康的功能益处:一项为期12个月的随机对照试验。
Exp Ther Med. 2025 Aug 11;30(4):192. doi: 10.3892/etm.2025.12942. eCollection 2025 Oct.
2
Role of irisin in physical activity, sarcopenia-associated type 2 diabetes, and cardiovascular complications.鸢尾素在体育活动、少肌症相关的2型糖尿病及心血管并发症中的作用。
World J Methodol. 2025 Dec 20;15(4):105462. doi: 10.5662/wjm.v15.i4.105462.
3
Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base (2025).

本文引用的文献

1
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.超重或肥胖成年人强化生活方式干预后使用替尔泊肽:SURMOUNT-3 期临床试验。
Nat Med. 2023 Nov;29(11):2909-2918. doi: 10.1038/s41591-023-02597-w. Epub 2023 Oct 15.
2
An update on diagnosis and therapeutics for type-2 diabetes mellitus.2型糖尿病诊断与治疗的最新进展
Bioinformation. 2023 Mar 31;19(3):295-298. doi: 10.6026/97320630019295. eCollection 2023.
3
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes: The SURPASS-6 Randomized Clinical Trial.
GLP-1疗法的新兴前沿:全面的证据基础(2025年)
Pharmaceutics. 2025 Aug 9;17(8):1036. doi: 10.3390/pharmaceutics17081036.
4
Effects of Blood-Glucose Lowering Therapies on Body Composition and Muscle Outcomes in Type 2 Diabetes: A Narrative Review.降糖疗法对2型糖尿病患者身体成分和肌肉结局的影响:一项叙述性综述
Medicina (Kaunas). 2025 Aug 1;61(8):1399. doi: 10.3390/medicina61081399.
5
Diabetes and Sarcopenia: Metabolomic Signature of Pathogenic Pathways and Targeted Therapies.糖尿病与肌肉减少症:致病途径的代谢组学特征及靶向治疗
Int J Mol Sci. 2025 Aug 5;26(15):7574. doi: 10.3390/ijms26157574.
6
Social Support's Dual Mechanisms in the Loneliness-Frailty Link Among Older Adults with Diabetes in Beijing: A Cross-Sectional Study of Mediation and Moderation.社会支持在北京糖尿病老年人孤独感与虚弱感关联中的双重机制:一项中介与调节作用的横断面研究
Healthcare (Basel). 2025 Jul 16;13(14):1713. doi: 10.3390/healthcare13141713.
7
Metabolic-associated enthesitis: a review on pathophysiology, clinical relevance, diagnostic challenges, and perspective on target treatments.代谢相关附着点炎:病理生理学、临床相关性、诊断挑战及靶向治疗前景综述
Immunol Res. 2025 Jul 11;73(1):106. doi: 10.1007/s12026-025-09655-0.
8
Association of serum chitinase-3-like protein 1 with sarcopenia in patients with type 2 diabetes mellitus.2型糖尿病患者血清几丁质酶-3样蛋白1与肌肉减少症的关联
J Endocrinol Invest. 2025 Jul 8. doi: 10.1007/s40618-025-02649-7.
9
The association of calf circumference with nutritional risk and mortality in type 2 diabetes aged over 80 years inpatient Chinese.中国80岁以上2型糖尿病住院患者小腿围与营养风险及死亡率的关联
Diabetol Metab Syndr. 2025 Jun 23;17(1):241. doi: 10.1186/s13098-025-01830-5.
10
The efficacy and safety of fecal microbiota transplantation in the treatment of sarcopenia: a retrospective study.粪便微生物群移植治疗肌肉减少症的疗效和安全性:一项回顾性研究。
J Transl Med. 2025 Jun 11;23(1):645. doi: 10.1186/s12967-025-06557-5.
替尔泊肽对比赖脯胰岛素添加至基础胰岛素治疗 2 型糖尿病:SURPASS-6 随机临床试验。
JAMA. 2023 Nov 7;330(17):1631-1640. doi: 10.1001/jama.2023.20294.
4
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study.口服司美格鲁肽可改善 2 型糖尿病患者的身体成分并保留瘦体重:一项 26 周的前瞻性真实世界研究。
Front Endocrinol (Lausanne). 2023 Sep 13;14:1240263. doi: 10.3389/fendo.2023.1240263. eCollection 2023.
5
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial.替尔泊肽降低肥胖或超重人群 2 型糖尿病发病风险:SURMOUNT-1 试验事后分析。
Diabetes Obes Metab. 2023 Dec;25(12):3748-3756. doi: 10.1111/dom.15269. Epub 2023 Sep 12.
6
Irisin deficiency exacerbates diet-induced insulin resistance and cardiac dysfunction in type II diabetes in mice.鸢尾素缺乏加剧了 II 型糖尿病小鼠的饮食诱导的胰岛素抵抗和心脏功能障碍。
Am J Physiol Cell Physiol. 2023 Oct 1;325(4):C1085-C1096. doi: 10.1152/ajpcell.00232.2023. Epub 2023 Sep 11.
7
Long-acting glucagon-like peptide 1 receptor agonists boost erectile function in men with type 2 diabetes mellitus complaining of erectile dysfunction: A retrospective cohort study.长效胰高血糖素样肽-1受体激动剂可改善伴有勃起功能障碍的2型糖尿病男性患者的勃起功能:一项回顾性队列研究。
Andrology. 2024 Mar;12(3):633-642. doi: 10.1111/andr.13519. Epub 2023 Aug 24.
8
GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway.胰高血糖素样肽-1受体激动剂利拉鲁肽和司美格鲁肽通过SIRT1通路改善肥胖诱导的肌肉萎缩。
Diabetes Metab Syndr Obes. 2023 Aug 15;16:2433-2446. doi: 10.2147/DMSO.S425642. eCollection 2023.
9
Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts.度拉糖肽通过抑制炎症和调节成肌细胞分化来保护小鼠免受糖尿病性肌肉减少症介导的肌肉损伤。
Int J Endocrinol. 2023 Aug 7;2023:9926462. doi: 10.1155/2023/9926462. eCollection 2023.
10
Effects of vitamin D on sex steroids, luteinizing hormone, and testosterone to luteinizing hormone ratio in 307 infertile men.307 例男性不育患者维生素 D 对性激素、促黄体生成素及睾酮/促黄体生成素比值的影响
Andrology. 2024 Mar;12(3):553-560. doi: 10.1111/andr.13505. Epub 2023 Aug 9.